Latest News
AFT Pharmaceuticals latest news
Stay updated with the latest advancements and breakthroughs in the pharmaceutical industry.
July 23, 2026
Pitt St Research initiates coverage on AFT Pharmaceuticals
AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd….
May 21, 2026
AFT delivers double digit revenue growth and record earnings
Operating profit or $24.4 million ahead of the guidance range….
May 18, 2026
AFT Pharmaceuticals names Stuart Houliston CFO
AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic pharmaceuticals company, today advises that Stuart Houliston will commence …
November 28, 2025
AFT Pharmaceuticals SA acquires the Hospital Division of Pharma Dynamics
AFT Pharmaceuticals SA (Pty) Ltd (‘AFT SA’) announces it has successfully completed the acquisition of the Hospital Division business of Pharma Dy…
November 20, 2025
AFT delivers 10th consecutive first half revenue increase
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…
November 12, 2025
AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market
AFT Pharmaceuticals has launched its full Lipo-Sachets® range in the U.S., featuring advanced collagen and vitamin supplements powered by patented LI…
September 25, 2025
On track for $300m FY27 revenue; positive iron IV study result
– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …
July 1, 2025
Combogesic IV launches in Canada; R&D progress
Q1 FY 26 HIGHLIGHTS – Maxigesic IV® (marketed as Combogesic IV®) launching in Canada this month and sales kick off for AFT Pharmaceuticals Canada a…
May 26, 2025
AFT and Hikma extend US Maxigesic Cooperation
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
May 1, 2024
AFT Licenses Maxigesic® IV in Brazil
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT, Massey Ventures, Gilles McIndoe to develop scar treatment
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT makes further progress in international markets
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….